UnitedHealth Group (NYSE:UNH) shares plunged in premarket trading Tuesday after the largest U.S. health insurer announced the unexpected departure of CEO Andrew Witty and suspended its 2025 financial forecast due to surging medical costs. The abrupt leadership change and withdrawn guidance come at a challenging time for the healthcare conglomerate, which has faced a series of setbacks over the past year.
UnitedHealth Announces Surprise CEO Exit, Pulls Forecast
UnitedHealth Group announced Tuesday that CEO Andrew Witty is stepping down for “personal reasons,” with the company providing no further details on the abrupt departure. Former CEO Stephen Hemsley, who has been with the healthcare conglomerate for 28 years, will return to the top role effective immediately.
The transition comes after a tumultuous period for the company, which has faced several significant challenges under Witty’s leadership.
In April, UnitedHealth posted its first earnings miss since the 2008 financial crisis and lowered its annual outlook, citing higher-than-expected medical costs and “unanticipated changes” in its Optum business that impacted planned 2025 reimbursements.
The company has also been grappling with the aftermath of a devastating cyberattack at its Change Healthcare (NASDAQ:CHNG) technology unit earlier this year that shut down much of the U.S. healthcare processing system for days, affecting some 200 million Americans.
Adding to the company’s troubles was the murder of Brian Thompson, UnitedHealth’s top health insurance executive, in December 2024. Citing ongoing concerns about surging medical costs, UnitedHealth also announced it is suspending its financial forecast for 2025.
The company now expects to return to growth only in 2026, signaling a longer recovery period than previously anticipated. The health insurance industry as a whole has been struggling with increased costs since mid-2023 due to a surge in demand for healthcare services, particularly under government-backed Medicare plans for older adults and individuals with disabilities.
UNH Stock Plunges in Premarket Trading
UnitedHealth Group shares were trading at $344.97 in premarket at 8:34 AM EST, down $33.78 or 8.92% from the previous close of $378.75. The stock has been under pressure in 2025, having already declined 0.50% on Monday and significantly underperforming the broader market year-to-date.
With today’s premarket losses, UNH is approaching the lower end of its 52-week range of $376.83 to $630.73. UnitedHealth’s market capitalization stood at approximately $343.58 billion based on Monday’s close, though that figure is set to decline substantially when markets open.
The company’s price-to-earnings ratio of 15.85 reflects its recent challenges, with forward P/E at 14.43 based on now-suspended guidance. UnitedHealth pays a dividend yield of 2.22% ($8.40 annually), with the ex-dividend date having passed on March 10, 2025.
The company’s premarket decline has also dragged down shares of other major health insurers, including CVS Health (NYSE:CVS) Corporation (down 3.23% at yesterday’s close), Cigna Group (NYSE:CI) (down 5.31%), and Oscar Health (NYSE:OSCR) (down 1.69%).
Despite current challenges, UnitedHealth maintains relatively strong financial metrics with a return on equity of 22.70% and $34.29 billion in cash on its balance sheet. The company generated $20.1 billion in levered free cash flow over the trailing twelve months.
Analyst sentiment had been cautiously optimistic prior to today’s announcement, with a consensus price target of $547.65, suggesting significant upside from current levels. However, this target will likely be revised downward given the suspended outlook.
Wall Street analysts had largely maintained “Buy” or “Strong Buy” ratings, with 7 Strong Buy, 19 Buy, and 1 Hold recommendations in the most recent period. Year-to-date, UnitedHealth stock has declined 24.81%, substantially underperforming the S&P 500’s modest 0.64% decline.
The healthcare giant has also lagged over 1-year and 3-year timeframes, down 24.96% and 17.30% respectively, compared to the S&P 500’s gains of 11.90% and 48.70% over the same periods.
***
Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions.
This article was originally published on The Tokenist. Check out The Tokenist’s free newsletter, Five Minute Finance, for weekly analysis of the biggest trends in finance and technology.